Table 1.
PCa patient characteristics for those with PSA ≤ 10 that developed biochemical recurrence or those that remained recurrence-free 5 years following radical prostatectomy.
| Variable | All patients (N=181) | Recurrence status at 5 years post-surgery | |
|---|---|---|---|
| Non-Recurrence (N=98) | Recurrence (N=83) | ||
| Age at surgery (Years) | |||
| Mean (± SD) | 59.98 (± 6.86) | 59.24 (± 7.04) | 60.86 (± 6.58) |
| Total Gleason | |||
| 5–6 | 60 (33.15) | 50 (83.33) | 10 (16.67) |
| 7 | 114 (62.98) | 48 (42.11) | 66 (57.89) |
| 8–9 | 7 (3.87) | 0 (0) | 7 (100) |
| Surgical margin | |||
| No | 139 (76.80) | 89 (64.03) | 50 (35.97) |
| Yes | 42 (23.20) | 9 (21.43) | 33 (78.57) |
| T stage | |||
| T2 | 142 (78.45) | 90 (63.38) | 52 (36.62) |
| T3 | 39 (21.55) | 8 (20.51) | 31 (79.49) |
| NCCN Risk Stratification | |||
| Low | 13 (7.18) | 12 (92.31) | 1 (7.69) |
| Interm.-Favorable | 97 (53.59) | 42 (43.30) | 55 (56.70) |
| Interm.-Unfavorable | 39 (21.55) | 10 (25.64) | 29 (74.36) |
| High | 7 (3.87) | 1 (14.29) | 6 (85.71) |
| Very High | 3 (1.66) | 1 (33.33) | 2 (66.66) |
| Pre-surgery PSA (ng/mL) | |||
| Median (IQR) | 5.00 (4.30 – 6.72) | 4.64 (3.90 – 6.30) | 5.60 (4.60 – 7.50) |
| sCD105 (ng/ml) | |||
| Median (IQR) | 5.54 (3.51 – 7.32) | 5.71 (4.06 – 7.63) | 5.2 (2.96 – 6.97) |
Data for Non-Recurrence or Recurrence columns are presented as number of patients (row %), mean (± SD) or median (IQR, interquartile range) as appropriate. The data for All patients are presented as number of patients (column %), mean (± SD) or median (IQR, interquartile range) as appropriate.